• Cell and gene therapy CRO market Trend and Market Forecast 2035

    In the last few years, many contract research organizations (CROs) have emerged and significantly impacted the overall biopharmaceutical market.

    It is worth mentioning that the presence of CROs has enabled small and mid-sized companies, which lack the necessary expertise and elaborate resources, to successfully initiate R&D programs in several domains.

    The financial opportunity within the Cell and Gene Therapy CROs Market has been analyzed across the following segments:
     Area of Expertise
     Cell Therapy
     Gene Therapy

     Scale of Operation
     Preclinical
     Clinical
     Drug Discovery

     Therapeutic Area
     Oncological Disorders
     Neurological Disorders
     Cardiovascular Disorders
     Infectious Diseases
     Metabolic Disorders
     Autoimmune Disorders
     Blood Disorders
     Rare / Genetic Disorders
     Ophthalmic Disorders
     Other disorders

     Analysis by Geographical Regions
     North America
     Europe
     Asia Pacific
     Latin America
     Middle East and North Africa

    The Cell and Gene Therapy CROs Market, 2022-2035 report features the following companies, which we identified to be key players in this domain:
     Altasciences
     Charles River Laboratories
     Creative Biolabs
     IQVIA
     Medpace
     PPD
     Precision for Medicine
     Accelera
     Evotec
     ICON
     Syneos Health
     CMIC Group
     Labcorp

    Table of Contents

    1. Preface

    2. Executive Summary

    3. Introduction

    4. Guide To Outsourcing

    5. Market Landscape

    6. Company Profiles

    7. Competitive Benchmarking

    8. Partnerships And Collaborations

    9. Mergers and Acquisitions

    10. Key Acquisition Targets

    11. Likely Partner Analysis for Cell Therapy CROs

    12. Likely Partner Analysis for Gene Therapy CROs

    13. Clinical Trial Analysis

    14. Total Cost of Ownership for Cell and Gene Therapy Contract Research Organizations

    15. Market Forecast and Opportunity Analysis

    16. Swot Analysis

    17. Conclusion

    18. Interview And Survey Transcripts

    19. Appendix 1: Tabulated Data

    20. Appendix 2: List of Companies and Organizations

    To view more details on this report, click on the link:
    https://www.rootsanalysis.com/reports/view_document/cell-and-gene-therapy-cros-market/230.html

    You may also be interested in the following titles:
    Women’s Digital Health Market

    Modular Manufacturing Facilities Market


    You may also like to learn what our experts are sharing in Roots educational series:
    Is Blue Ocean Strategy The Silver Bullet For Emerging Teleradiology Players to Achieve A Breakthrough In This Highly Competitive Market?

    Artificial Intelligence (AI) In Oncology: Current Scenario And Future Potential

    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    #CellandgenetherapyCROMarketTrends #Cell and gene therapy #CROMarketShare #atmps #genetherapycro #cellandgenetherapycompanies
    Cell and gene therapy CRO market Trend and Market Forecast 2035 In the last few years, many contract research organizations (CROs) have emerged and significantly impacted the overall biopharmaceutical market. It is worth mentioning that the presence of CROs has enabled small and mid-sized companies, which lack the necessary expertise and elaborate resources, to successfully initiate R&D programs in several domains. The financial opportunity within the Cell and Gene Therapy CROs Market has been analyzed across the following segments:  Area of Expertise  Cell Therapy  Gene Therapy  Scale of Operation  Preclinical  Clinical  Drug Discovery  Therapeutic Area  Oncological Disorders  Neurological Disorders  Cardiovascular Disorders  Infectious Diseases  Metabolic Disorders  Autoimmune Disorders  Blood Disorders  Rare / Genetic Disorders  Ophthalmic Disorders  Other disorders  Analysis by Geographical Regions  North America  Europe  Asia Pacific  Latin America  Middle East and North Africa The Cell and Gene Therapy CROs Market, 2022-2035 report features the following companies, which we identified to be key players in this domain:  Altasciences  Charles River Laboratories  Creative Biolabs  IQVIA  Medpace  PPD  Precision for Medicine  Accelera  Evotec  ICON  Syneos Health  CMIC Group  Labcorp Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Guide To Outsourcing 5. Market Landscape 6. Company Profiles 7. Competitive Benchmarking 8. Partnerships And Collaborations 9. Mergers and Acquisitions 10. Key Acquisition Targets 11. Likely Partner Analysis for Cell Therapy CROs 12. Likely Partner Analysis for Gene Therapy CROs 13. Clinical Trial Analysis 14. Total Cost of Ownership for Cell and Gene Therapy Contract Research Organizations 15. Market Forecast and Opportunity Analysis 16. Swot Analysis 17. Conclusion 18. Interview And Survey Transcripts 19. Appendix 1: Tabulated Data 20. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/view_document/cell-and-gene-therapy-cros-market/230.html You may also be interested in the following titles: Women’s Digital Health Market Modular Manufacturing Facilities Market You may also like to learn what our experts are sharing in Roots educational series: Is Blue Ocean Strategy The Silver Bullet For Emerging Teleradiology Players to Achieve A Breakthrough In This Highly Competitive Market? Artificial Intelligence (AI) In Oncology: Current Scenario And Future Potential About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #CellandgenetherapyCROMarketTrends #Cell and gene therapy #CROMarketShare #atmps #genetherapycro #cellandgenetherapycompanies
    WWW.ROOTSANALYSIS.COM
    Cell and Gene Therapy CRO | Industry Analysis | Market Size | 2035
    Driven by rapid interest in cell and gene therapies (evident from over 3500 ATMPs being investigated), the cell and gene therapy CRO market is anticipated to grow at over 18% CAGR
    0 Yorumlar 0 hisse senetleri
  • Cell and gene therapy CRO market, Industry Analysis, and Forecast to 2035

    Characterized by high prevalence rate of rare and genetic disorders, and rise in demand for effective novel ATMPs, the cell and gene therapy contract research industry is likely to witness evolutionary advancements, in the coming years

    Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell and Gene Therapy CROs Market, 2022-2035”.

    The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
     A detailed overview of the overall market landscape of the cell and gene therapy CROs, based on several relevant parameters, such as year of establishment, company size, location of headquarters, area of expertise, scale of operation and types of services offered.
     A detailed analysis on the business models that are commonly adopted by the biopharmaceutical industry for outsourcing cell and gene therapies.
     Elaborate profiles of key industry players based in North America, Europe and Asia-Pacific that offer contract research services.
     A benchmark analysis of the various players engaged in this domain. It highlights the capabilities of the companies.
     An analysis of the recent collaborations within the cell and gene therapy contract research industry, during the period 2015-2022.
     A detailed analysis of the various mergers and acquisitions that have taken place in this domain, during the period 2015-2022.
     A detailed acquisition target analysis, taking into consideration historical trend of the activity of players that have acquired other firms since 2015.
     A detailed discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry’s evolution highlighting the relative effect of each SWOT parameter on the overall cell and gene therapies research services industry.
     A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

     Area of Expertise
     Cell Therapy
     Gene Therapy

     Scale of Operation
     Preclinical
     Clinical
     Drug Discovery

     Therapeutic Area
     Oncological Disorders
     Neurological Disorders
     Cardiovascular Disorders
     Infectious Diseases
     Metabolic Disorders
     Autoimmune Disorders
     Blood Disorders
     Rare / Genetic Disorders
     Ophthalmic Disorders
     Other disorders

     Analysis by Geographical Regions
     North America
     Europe
     Asia Pacific
     Latin America
     Middle East and North Africa

    Key companies covered in the report
     Altasciences
     Charles River Laboratories
     Creative Biolabs
     IQVIA
     Medpace
     PPD
     Precision for Medicine
     Accelera
     Evotec
     ICON
     Syneos Health
     CMIC Group
     Labcorp

    To view more details on this report, click on the link:
    https://www.rootsanalysis.com/reports/view_document/cell-and-gene-therapy-cros-market/230.html

    You may also be interested in the following titles:
    Cell Therapy Manufacturing Market
    Global TCR Therapy Market

    You may also like to learn what our experts are sharing in Roots educational series:
    Is Blue Ocean Strategy The Silver Bullet For Emerging Teleradiology Players to Achieve A Breakthrough In This Highly Competitive Market?

    CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications

    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    #CellandgenetherapyCROMarketTrends #CellandgenetherapyCROMarketShare #atmps #genetherapycro #cellandgenetherapycompanies
    Cell and gene therapy CRO market, Industry Analysis, and Forecast to 2035 Characterized by high prevalence rate of rare and genetic disorders, and rise in demand for effective novel ATMPs, the cell and gene therapy contract research industry is likely to witness evolutionary advancements, in the coming years Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell and Gene Therapy CROs Market, 2022-2035”. The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:  A detailed overview of the overall market landscape of the cell and gene therapy CROs, based on several relevant parameters, such as year of establishment, company size, location of headquarters, area of expertise, scale of operation and types of services offered.  A detailed analysis on the business models that are commonly adopted by the biopharmaceutical industry for outsourcing cell and gene therapies.  Elaborate profiles of key industry players based in North America, Europe and Asia-Pacific that offer contract research services.  A benchmark analysis of the various players engaged in this domain. It highlights the capabilities of the companies.  An analysis of the recent collaborations within the cell and gene therapy contract research industry, during the period 2015-2022.  A detailed analysis of the various mergers and acquisitions that have taken place in this domain, during the period 2015-2022.  A detailed acquisition target analysis, taking into consideration historical trend of the activity of players that have acquired other firms since 2015.  A detailed discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry’s evolution highlighting the relative effect of each SWOT parameter on the overall cell and gene therapies research services industry.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Area of Expertise  Cell Therapy  Gene Therapy  Scale of Operation  Preclinical  Clinical  Drug Discovery  Therapeutic Area  Oncological Disorders  Neurological Disorders  Cardiovascular Disorders  Infectious Diseases  Metabolic Disorders  Autoimmune Disorders  Blood Disorders  Rare / Genetic Disorders  Ophthalmic Disorders  Other disorders  Analysis by Geographical Regions  North America  Europe  Asia Pacific  Latin America  Middle East and North Africa Key companies covered in the report  Altasciences  Charles River Laboratories  Creative Biolabs  IQVIA  Medpace  PPD  Precision for Medicine  Accelera  Evotec  ICON  Syneos Health  CMIC Group  Labcorp To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/view_document/cell-and-gene-therapy-cros-market/230.html You may also be interested in the following titles: Cell Therapy Manufacturing Market Global TCR Therapy Market You may also like to learn what our experts are sharing in Roots educational series: Is Blue Ocean Strategy The Silver Bullet For Emerging Teleradiology Players to Achieve A Breakthrough In This Highly Competitive Market? CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #CellandgenetherapyCROMarketTrends #CellandgenetherapyCROMarketShare #atmps #genetherapycro #cellandgenetherapycompanies
    WWW.ROOTSANALYSIS.COM
    Cell and Gene Therapy CRO | Industry Analysis | Market Size | 2035
    Driven by rapid interest in cell and gene therapies (evident from over 3500 ATMPs being investigated), the cell and gene therapy CRO market is anticipated to grow at over 18% CAGR
    0 Yorumlar 0 hisse senetleri